Dr. Krishna Gundabolu, MBBS

Claim this profile

University of Nebraska

Studies Burkitt Lymphoma
Studies Acute Lymphoblastic Leukemia
4 reported clinical trials
17 drugs studied

Area of expertise

1Burkitt Lymphoma
Krishna Gundabolu, MBBS has run 3 trials for Burkitt Lymphoma. Some of their research focus areas include:
CD22 positive
Philadelphia chromosome/BCR-ABL1 negative
CD19 positive
2Acute Lymphoblastic Leukemia
Krishna Gundabolu, MBBS has run 2 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:
Stage I
Stage II
CD22 positive

Affiliated Hospitals

Image of trial facility.
Nebraska Medicine-Village Pointe
Image of trial facility.
University Of Nebraska Medical Center

More about Krishna Gundabolu, MBBS

Clinical Trial Related8 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 0 Active Clinical Trials
Treatments Krishna Gundabolu, MBBS has experience with
  • Inotuzumab Ozogamicin
  • WU-CART-007
  • Allopurinol
  • Bone Marrow Aspiration And Biopsy
  • Cyclophosphamide
  • Cytarabine

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Krishna Gundabolu, MBBS specialize in?
Is Krishna Gundabolu, MBBS currently recruiting for clinical trials?
Are there any treatments that Krishna Gundabolu, MBBS has studied deeply?
What is the best way to schedule an appointment with Krishna Gundabolu, MBBS?
What is the office address of Krishna Gundabolu, MBBS?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security